I Can See Health

   Chapter 333 Refused to sponsor!

   Jinghua City, AstraZeneca branch.

  Wang Ruoxi finally returned to work after a short vacation.

   "Manager Wang, this is the sales report of Dapagliflozin last month."

   A little secretary in uniform came to Wang Ruoxi's office.

   "Last month, the main sales were mainly concentrated in several affiliated hospitals of Jinghua Medical University, Jinghua No. 1, No. 2, and No. 4. Because the No. 3 hospital is an oncology hospital, the sales of Dapagliflozin are very small."

  Wang Ruoxi hummed softly, and then opened the sales report.

   After a while, she frowned.

   "How come the sales volume of Jinghua No. 1 and No. 2 are similar?"

   The number of beds in the Cardiology Department of Jinghua Second Hospital is hundreds more than that of Jinghua First Hospital.

   The sales volume of the cardiology departments of the two hospitals is almost the same, which is very strange.

   "This...I don't know very well." The uniformed secretary whispered, "But from the sales department, it seems that the promotion in the Jinghua Second Hospital is not going well."

   "Why?" Wang Ruoxi said.

"It's mainly Director Cao of the Second Hospital. He is very strict in this aspect, and I heard that the Cardiology Department of the Second Hospital is applying for the National Key Laboratory of the Ministry of Education, so Director Cao has been in Kyoto recently, not in Jinghua. We sell The representative has no chance to see him." The uniformed secretary said.

   "Well, let's do this first." Wang Ruoxi thought about it and said, "After Director Cao returns to Jinghua, make an appointment with me, and I will visit him in person."

   "Okay." The uniformed secretary nodded.

   "Okay, you go out first."

   After Wang Ruoxi sent his subordinates away, he began to process the documents for the week.

   All the company's schedules and major meetings, she will personally look over, and then hand over to the secretary.

   Turn on the computer and look through the emails during this period.

   She suddenly caught a glimpse of an unread unfamiliar email.

  Wang Ruoxi thought it was spam and was about to delete it, but accidentally saw the subject of the email.

   "On the application of dapagliflozin in patients with acute myocardial infarction..."

   "This topic is quite interesting."

  Wang Ruoxi gave up the thought of deleting it, and opened the email gently.

   Her recent main work is on the drug Dapagliflozin.

  AstraZeneca has regarded Dapagliflozin as an epoch-making drug for the treatment of heart failure, which has been written into clinical guidelines after all.

   The strategic focus of the entire company has been fully inclined to this new star in the field of hypoglycemia.

   Therefore, Wang Ruoxi knows all the experimental projects about Dapagliflozin very well.

   However, this is the first time she has seen relevant research on the use of dapagliflozin in patients with acute myocardial infarction!

  …

   "How did I receive this email?" Wang Ruoxi was only going to take a few glances, just take a look.

   If it weren't for the attractive topic, she might not even read it.

   However, when she read the entire study, she was a little stunned.

   This study is quite mature, and the content of the study is "Dapagliflozin prevents heart failure in patients with acute myocardial infarction".

  The entire research report has no major flaws.

   "If this can give a positive result, it will definitely push Dapagliflozin to another peak!"

  Wang Ruoxi is very excited, she is very optimistic about this research project.

   The only flaw in this study is that the sample size is really too small!

   "Who would send me this kind of email?"

  This research report is quite amazing!

  Wang Ruoxi turned back to find the sender of the email.

   "[email protected]..." Wang Ruoxi was stunned when she saw the signature on the email, "Is this Lu Chen?"

   She suddenly recalled that Lu Chen had indeed told him that he would send a copy of his dapagliflozin research report.

   But afterwards, she was going to find any reason to reject Lu Chen, so she didn't care too much.

   "I almost missed such a good idea!"

   "But... Didn't he just study one?" Wang Ruoxi couldn't believe her eyes.

   If the other party is a doctoral student, she will feel a little easier.

   But, Lu Chen is just a first grade student!

   "Forget it, this clinical study is definitely valuable!"

  Wang Ruoxi immediately reported Lu Chen's research to the company's top management.

   At the same time, she also sent Lu Chen a WeChat message immediately.

   "Don't reply to WeChat?"

  Wang Ruoxi called Lu Chen again, but he didn't answer the phone.

   After she contacted her younger brother Wang Zihao, she found out that Lu Chen was on the night shift last night.

   "It seems that I can only contact him in the afternoon."

  Wang Ruoxi refocused on Lu Chen's clinical research.

   She believes that AstraZeneca's executives will definitely value this clinical research report.

  …

   Half an hour later, Wang Ruoxi received a reply from the company's top management.

   "What? Rejected?"

   She couldn't believe her eyes. The company actually refused this sponsorship without giving any reason.

   "It doesn't make sense!" Wang Ruoxi frowned.

   She re-read all the previous clinical studies and did not see any similar studies.

   But after a few years of struggle after graduation, Wang Ruoxi also has a certain network of contacts at the company headquarters.

   She immediately consulted the relevant personnel at the headquarters and finally got an answer.

  CLINICALTRIALS, the largest clinical trial platform abroad, has the recruitment of similar patients.

   This means that there are already foreign institutions that are conducting such research and sponsored by AstraZeneca.

  AstraZeneca will naturally not spend a second share of money on the same research area.

   However, foreign clinical research is also in the initial stage of patient recruitment, and has not officially started, and no papers have been published.

   This is also the reason why Wang Ruoxi did not find any relevant literature.

   "It seems that this sponsorship is out of the question." Wang Ruoxi was a little disappointed.

   Encountering a good clinical study is extremely difficult!

  Wang Ruoxi is really unwilling!

  …

   Jinghua Second Hospital, the dormitory of Jipei Building.

   When Lu Chen woke up, it was already one o'clock in the afternoon.

   He opened his eyes and was shocked when he saw the time on the phone.

   "Oops, I'm going to be late!"

  Today is the first day of his electrophysiological simulation surgery.

   The specified time starts at half past one in the afternoon.

  Lu Chen set three alarm clocks around twelve o'clock, but it was of no use and didn't wake him up.

  No way, I was so tired last night that Lu Chen hardly slept all night.

  Lu Chen got up immediately, and didn't have time to check the missed calls and WeChat messages on his phone.

   After taking a shower, he didn't even have time to eat lunch, so he ran to the cardiac catheterization room.

   The simulated operating room is also in the catheterization room of the Cardiology Department, but it is in a relatively independent room next to the catheterization room.

   When Lu Chen arrived at the simulated operation room on the fourth floor, it was exactly half past one.

   At this time, there were four people standing at the door of the simulated operating room.

A person led by   , Lu Chen knew, he was Cheng Guowen, chairman of the Jinghua Electrophysiology Association, and also the ward director of the Jinghua Second Hospital.

   Of the other three people, Lu Chen only knew one of them, and that was Lei Cui.

   The faces of the other two were very unfamiliar, and Lu Chen did not know each other.

   (end of this chapter)